Clinical characteristics of patients intolerant to VVIR pacing

American Journal of Cardiology

Volumn 86, Issue 1, 2000, Pages 59-63

  Ellenbogen, Kenneth A ^a   Stambler, Bruce S ^b   Orav, E John ^c   Sgarbossa, Elena B ^d,e   Tullo, Nicholas G ^f   Love, Charles A ^g   Wood, Mark A ^a   Goldman, Lee ^h   Lamas, Gervasio A ⁱ  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^g THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FOLLOW UP; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; BRADYCARDIA; CARDIAC PACING, ARTIFICIAL; DYSPNEA; EDEMA; ELECTROCARDIOGRAPHY; FEMALE; FOOT; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; MALE; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SINGLE-BLIND METHOD; SYNCOPE;

EID: 0034237519     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00828-6     Document Type: Article

References (29)

1. Santini M., Alexidou G., Ansalone G., Cacciatore G., Cini R., Turitto G. Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing. Am J Cardiol. 65:1990;729-735.
2. Markewwitz A., Schad N., Hemmer W., Bernheim C., Ciavolollela M., Weihold C. What is the most appropriate stimulation mode in patients with sinus node dysfunction? Pacing Clin Electrophysiol. 9:1986;1115-1120.
3. Feuer J., Shandling A., Messenger J., Castallanet C., Thomas L. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol. 64:1989;1376-1379.
4. Sutton R., Kenny R.A. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol. 9:1986;1110-1114.
5. Rosenqvist M., Brandt J., Schuller H. Long-term pacing in sinus node disease; the effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 116:1988;16-22.
6. Stangl K., Seitz K., Wirtzfeld A., Ah E., Blomer H. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol. 13:1990;2080-2085.
7. Hesselson A.B., Parsonnet V., Bernstein A.D., Bonavita G.L. Deleterious effects of long-term single chamber ventricular pacing in patients with sick sinus syndrome the hidden benefits fo dual chamber pacing . J Am Coll Cardiol. 17:1992;1542-1549.
8. Connolly S.J., Kerr C., Gent M., Yusuf S. Dual-chamber versus ventricular pacing Critical appraisal of current data . Circulation. 94:1996;578-583.
9. Lamas G.A. Pacemaker mode selection and survival a plea to apply the principles of evidence based medicine to cardiac pacing practice . Heart. 78:1997;218-220.
10. Toff W.D., Skehan J.D., De Bono D.P., Camm A.J. The United Kingdom pacing and cardiovascular events (UKPACE) trial. Heart. 78:1997;221-223.
11. Ovsyhcher I.E., Hayes D.L., Furman S. Dual-Chamber pacing is superior to ventricular pacing. Fact or Controversy? Circulation. 97:1998;2368-2370.
12. Andersen H.R., Thuesen L., Bagger J.P., Vesterlund T., Bloch-Thomsen P.E. Prospective randomized trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet. 344:1994;1523-1528.
13. Lamas G.A., Orav E.J., Stambler B.S., Ellenbogen K.A., Sgarbossa E.B., Huang S.K.S., Marinchak R.A., Estes N.A.M. III, Mitchell G.F., Lieberman E.H., Mangione C.M., Goldman L. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med. 338:1998;1097-1104.
14. Asubel K., Furman S. The pacemaker syndrome. Ann Intern Med. 103:1985;420-429.
15. Ellenbogen K.A., Gilligan D.M., Wood M.A., Morillo C.A., Barold S.S. The pacemaker syndrome - a matter of definition. Am J Cardiol. 79:1997;1226-1229.
16. Nishimura R.A., Gersh B.J., Vliestra R.E., Osborn M.J., Ilstrup D.M., Holmes D.R. Hemodynamic and symptomatic consequences of ventricular pacing. PACE. 5:1982;903-910.
17. Heldman D., Mulvihill D., Nguyen H., Messenger J.C., Rylaarsdam A., Evans K., Castellanet M.J. True incidence of pacemaker syndrome. PACE. 13:1990;1742-1750.
18. Sulke N., Chambers J., Dritsas A., Sowton E. A randomized double-blind crossover comparison of four rate-responsive pacing modes. J Am Coll Cardiol. 17:1991;696-706.
19. Sulke N., Dritsas A., Bostock J., Wells A., Morris R., Sowton E. "Subclinical" pacemaker syndrome a randomized study of symptom-free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices . Br Heart J. 67:1992;57-64.
20. Stewart W.J., Dicola V.C., Harthorne J.W.W., Gilliam L.D., Weyman A.E. Doppler ultrasound measurement of cardiac output in patients with physiologic pacemakers. Am J Cardiol. 54:1984;308-312.
21. Rediker D.E., Eagle K.A., Homma S., Gillam L.D., Harthorne J.W. Clinical and hemodynamic comparison of VVI versus DDD pacing inpatients with DDD pacemakers. Am J Cardiol. 61:1988;323-329.
22. Sorrrentino R.A., Wharton J.M., DeAntonio H., Natale A., Brodine W., Steinhaus D., Hafley G., Lee K.L. Pacemaker syndrome in the Pacemaker Atrial Tachycardia Trial. (abstr) J Am Coll Cardiol. 33:1999;141A.
23. Ellenbogen K.A., Wood M.A., Stambler B. Pacemaker syndrome clinical, hemodynamic, and neurohumoral features . Barold S.S., Mugica J. New Perspectives in Cardiac Pacing. Vol. 3:1993;85-112 Futura Publishing, Mount Kisco, NY.
24. Pearson A.C., Janosik D.L., Redd R.M., Buckingham T.A., Labovitz A.J. Hemodynamic benefit of atrioventricular synchrony prediction from baseline Doppler echocardiographic variables . J Am Coll Cardiol. 13:1989;1613-1621.
25. Ellenbogen K.A., Thames M.D., Mohanty P.K. New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. Am J Cardiol. 65:1990;53-59.
26. Taylor J.A., Morillo C.A., Eckberg D.L., Ellenbogen K.A. Higher sympathetic nerve activity during ventricular (VVI) pacing than dual chamber (DDD) pacing a potential mechanism for improved survival with DDD pacing . J Am Coll Cardiol. 28:1996;1753-1758.
27. Stagl K., Weil J., Seitz K., Laule M., Gerzer R. Influence of AV synchrony on the plasma level of atrial natriuretic peptide (ANP) in patients with total AV block. PACE. 11:1988;1176-1181.
28. Erlebacher J.A., Danner R.L., Stelzer P.E. Hypotension with ventricular pacing an atrial vasodepressor reflex in human beings . J Am Coll Cardiol. 4:1984;550-555.
29. Mittleman R.S., Orav E.J., Goldman L., Ellenbogen K.A., Huang S., Lamas G.A. Effects of mode changing from single chamber to dual chamber pacing on quality of life in the elderly results from a multicenter prospective trial . (abstr) PACE. 21:(suppl. II):1998;934.